Kudos to BMJ. 

BMJ Table of Contents, May 31, 2003 - "Time to untangle doctors from drug companies"

To search BMJ for any of the following articles, copy the entire title (or as many of the words as will fit in the space) in the section called "Word(s) in Title or Abstract":

Characteristics of general practitioners who frequently see drug industry representatives: national cross sectional study

Charities and patient groups should declare interests

Drug company sponsorship of education could be replaced at a fraction of its cost

Drug representatives may increase unnecessary GP prescribing

Evidence b(i)ased medicine—selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications

How can research ethics committees protect patients better?

How to dance with porcupines: rules and guidelines on doctors' relations with drug companies

Information from drug companies and opinion leaders - Double standards in information for medical journals and practitioners should go

Journals should select drug advertisements more carefully

Medical journals and pharmaceutical companies: uneasy bedfellows

No more free lunches - Patients will benefit from doctors and drug companies disentangling

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

Relationships between the pharmaceutical industry and patients' organisations

Reporting of clinical trials of drugs shows bias

Research sponsored by drug companies is biased

Schering uses German medical association to promote HRT

Unhealthy spin

Who pays for the pizza? Redefining the relationships between doctors and drug companies. 2: Disentanglement

Who pays for the pizza? Redefining the relationships between doctors and drug companies. 1: Entanglement

World Medical Association reviews doctors’ links with drug companies

Sandy Mintz               

"Eternal vigilance is the price of liberty." - Wendell Phillips (1811-1884), paraphrasing John Philpot Curran (1808)